Organon (OGN) Misses Q4 EPS by 1c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Organon & Co. (OGN) PT Lowered to $19 at Goldman Sachs
February 14, 2025 11:58 AM ESTGoldman Sachs analyst Chris Shibutani lowered the price target on Organon & Co. (NYSE: OGN) to $19.00 (from $20.00) while maintaining a Neutral rating.
The analyst comments "OGN shares outperformed (+11% vs. +1% SPX on the day) in the context of 4Q24 results that were generally in line with expectations overall. FY2025 guidance - that actually came in slightly... More
